India Records 38% Decline in TB Mortality Since 2015, WHO Report Shows
India has recorded a 38 per cent decline in tuberculosis (TB)-related deaths since 2015, surpassing the global reduction of 35 per cent, according to the World Health Organization’s (WHO) Global Tuberculosis Report 2026. The country has also achieved a 94 per cent treatment success rate among patients with drug-susceptible TB. The report highlights that the South-East Asia Region accounted for the largest share of new TB cases globally in 2025, at 35 per cent, followed by the Western Pacific Region at 27 per cent and the African Region at 25 per cent. Around 88 per cent of newly reported TB cases were concentrated in 30 countries. India alone contributed approximately a quarter of the global burden, followed by Indonesia (10 per cent), the Philippines (6.8 per cent), China (6.5 per cent), Pakistan (6.4 per cent), Nigeria (4.9 per cent), the Democratic Republic of the Congo (3.9 per cent) and Bangladesh (3.7 per cent). The five countries with the highest burden collectively accounted for 55 per cent of global cases. Globally, TB continues to impose a significant financial burden on affected households. Nearly half of people receiving TB treatment and their families face catastrophic expenses, exceeding 20 per cent of their total household income, when medical and non-medical costs and income losses are taken into account. The report also identifies several factors that increase the risk of developing TB, including HIV infection, undernutrition, diabetes and tobacco use. An estimated 9.6 lakh new cases were linked to undernutrition, 9.2 lakh to diabetes, 7.3 lakh to alcohol use disorders, 6.9 lakh to smoking and 5.5 lakh to HIV infection. Worldwide, approximately 10.6 million people developed TB in 2025, including 5.7 million men, 3.7 million women and 1.2 million children. The disease claimed an estimated 1.13 million lives during the year, remaining the world’s leading cause of death from a single infectious agent. Drug-resistant tuberculosis, particularly multidrug-resistant TB (MDR-TB), continues to pose a serious public health and health security challenge. Only around two in five people diagnosed with drug-resistant TB received treatment in 2025. However, global interventions against the disease have helped save an estimated 86 million lives since 2000. In India, the TB Mukt Bharat Abhiyaan has expanded screening efforts significantly. Between December 7, 2024, and November 8, 2026, the campaign brought more than 25 crore individuals within the ambit of TB screening activities. According to the Union Health Ministry, the decline in TB mortality has been driven by interventions under the National TB Elimination Programme (NTEP). These include active case detection using AI-enabled X-rays, rapid diagnostic services, timely treatment initiation, differentiated care and nutritional assistance through the Nikshay Poshan Yojana and Nikshay Mitra initiative. The ministry also highlighted the use of artificial intelligence tools to identify disease hotspots, predict high-risk patients likely to experience adverse outcomes and support patient engagement through Khushi, an AI-powered chatbot and avatar-based videobot. Tuberculosis is a bacterial infectious disease that primarily affects the lungs and spreads through the air when an infected person coughs, sneezes or spits. Despite its continued global impact, the disease is both preventable and curable. Source: The Hindu
India Records 38% Decline in TB Mortality Since 2015, WHO Report Shows Read More »









